After Hours Gainer
SLGL Sol-Gel Technologies Ltd.7.59-0.06-0.8%
After Hours:8.47+0.88 (+11.6%)
Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay for the Treatment of Inflammatory Lesions of Rosacea
Globe NewswireThu, 10-Sep 4:01 PM
Premarket Decliner
SLGL Sol-Gel Technologies Ltd.14.00+1.71+13.9%
Premarket:11.25-2.75 (-19.6%)
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase Ordinary Shares
Globe NewswireFri, 14-Feb 6:45 AM
Premarket Gainer
SLGL Sol-Gel Technologies Ltd.9.23-0.57-5.8%
Premarket:23.00+13.77 (+149.2%)
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo for the Treatment of Acne Vulgaris
Globe NewswireMon, 30-Dec 7:05 AM